Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Increased Procalcitonin Levels in End Stage Renal Disease and Chronic Kidney Disease as An Indicator of Inflammatory Activation

Vinod Bansal, Daniel Fareed, Debra Hoppensteadt, Josephine Cunanan, Jawed Fareed

Blood (2008) 112 (11): 5472.

https://doi.org/10.1182/blood.V112.11.5472.5472

Published: 2008

Journal Articles

Modulation of Platelet Function by Recombinant Thrombomodulin Hematologic Implications.

Cafer Adiguzel, MD, Omer Iqbal, M.D., Daniel Fareed, B.S., Debra Hoppensteadt, Ph.D., Walter Jeske, Ph.D., Michael Simmikannu, B.S., Jawed Fareed, Ph.D.

Blood (2007) 110 (11): 3898.

https://doi.org/10.1182/blood.V110.11.3898.3898

Published: 2007

Journal Articles

Nitric Oxide and Asymmetric Dimethlyarginine Levels in Malignancy Associated Thrombosis and Their Modulaiton by Anticoagulants.

Debra Hoppensteadt, PhD, Daniel Fareed, BS, Omer Iqbal, MD, Ajit Lale, MD, Jawed Fareed, PhD

Blood (2006) 108 (11): 1477.

https://doi.org/10.1182/blood.V108.11.1477.1477

Published: 2006

Journal Articles

Synthetic Anti-Xa Drugs Can Be Used for Parenteral Anticoagulation but Not Fondaparinux.

Omer Iqbal, M.D., Debra Hoppensteadt, Ph.D., Daniel Fareed, B.S., Jawed Fareed, Ph.D..

Blood (2004) 104 (11): 4088.

https://doi.org/10.1182/blood.V104.11.4088.4088

Published: 2004

Journal Articles

Differential down Regulation of Inflammatory Cytokines, CRP, CD 40-L, MCP-1 and NO Levels in Malignancy Associated Thrombosis by Extended Treatment of Enoxaparin and Warfarin.

Jawed Fareed, Ph.D., Debra A. Hoppensteadt, Ph.D., Susannah Cort, Ph.D., Omer Iqbal, M.D., Peter Bacher, M.D., Daniel Fareed, B.S., Michelle Florian, B.S., Steven Deitcher, M.D.

Blood (2004) 104 (11): 2595.

https://doi.org/10.1182/blood.V104.11.2595.2595

Published: 2004

Journal Articles

Argatroban, Not Lepirudin or Bivalirudin, Treatment Results in the Generation of Nitric Oxide during Parenteral Administration.

Jeanine M. Walenga, PhD, Daniel Fareed, BS, Chris Schultz, BS, Brian Neville, BS, Debra Hoppensteadt, PhD, Omer Iqbal, MD, Jawed Fareed, PhD

Blood (2004) 104 (11): 1849.

https://doi.org/10.1182/blood.V104.11.1849.1849

Published: 2004

NARROW

Increased Procalcitonin Levels in End Stage Renal Disease and Chronic Kidney Disease as An Indicator of Inflammatory Activation

Modulation of Platelet Function by Recombinant Thrombomodulin Hematologic Implications.

Nitric Oxide and Asymmetric Dimethlyarginine Levels in Malignancy Associated Thrombosis and Their Modulaiton by Anticoagulants.

Synthetic Anti-Xa Drugs Can Be Used for Parenteral Anticoagulation but Not Fondaparinux.

Differential down Regulation of Inflammatory Cytokines, CRP, CD 40-L, MCP-1 and NO Levels in Malignancy Associated Thrombosis by Extended Treatment of Enoxaparin and Warfarin.

Argatroban, Not Lepirudin or Bivalirudin, Treatment Results in the Generation of Nitric Oxide during Parenteral Administration.

Email alerts

ASH Publications

American Society of Hematology

Increased Procalcitonin Levels in End Stage Renal Disease and Chronic Kidney Disease as An Indicator of Inflammatory Activation

Modulation of Platelet Function by Recombinant Thrombomodulin Hematologic Implications.

Nitric Oxide and Asymmetric Dimethlyarginine Levels in Malignancy Associated Thrombosis and Their Modulaiton by Anticoagulants.

Synthetic Anti-Xa Drugs Can Be Used for Parenteral Anticoagulation but Not Fondaparinux.

Differential down Regulation of Inflammatory Cytokines, CRP, CD 40-L, MCP-1 and NO Levels in Malignancy Associated Thrombosis by Extended Treatment of Enoxaparin and Warfarin.

Argatroban, Not Lepirudin or Bivalirudin, Treatment Results in the Generation of Nitric Oxide during Parenteral Administration.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only